These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 29246612

  • 1. Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases.
    Sharaf-Eldin WE, Kishk NA, Gad YZ, Hassan H, Ali MAM, Zaki MS, Mohamed MR, Essawi ML.
    J Neurol Sci; 2017 Dec 15; 383():188-198. PubMed ID: 29246612
    [Abstract] [Full Text] [Related]

  • 2. Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
    Keller A, Leidinger P, Meese E, Haas J, Backes C, Rasche L, Behrens JR, Pfuhl C, Wakonig K, Gieß RM, Jarius S, Meder B, Bellmann-Strobl J, Paul F, Pache FC, Ruprecht K.
    J Neuroinflammation; 2015 Oct 31; 12():196. PubMed ID: 26521232
    [Abstract] [Full Text] [Related]

  • 3. Potential Value of miR-23a for Discriminating Neuromyelitis Optica Spectrum Disorder from Multiple Sclerosis.
    Sharaf-Eldin W, Kishk N, Sakr B, El-Hariri H, Refeat M, ElBagoury N, Essawi M.
    Arch Iran Med; 2020 Oct 01; 23(10):678-687. PubMed ID: 33107309
    [Abstract] [Full Text] [Related]

  • 4. MicroRNAs Correlate with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in a Chinese Population.
    Chen J, Zhu J, Wang Z, Yao X, Wu X, Liu F, Zheng W, Li Z, Lin A.
    Med Sci Monit; 2017 May 27; 23():2565-2583. PubMed ID: 28550707
    [Abstract] [Full Text] [Related]

  • 5. Differentiation of remitting neuromyelitis optica spectrum disorders from multiple sclerosis by integrating parameters from serum proteins and lymphocyte subsets.
    Ip PP, Chung CY, Chang CC, Lee YF, Wang HM, Lian IB, Fann CS, Yang CC, Liao F.
    J Neuroimmunol; 2018 May 15; 318():45-52. PubMed ID: 29455925
    [Abstract] [Full Text] [Related]

  • 6. Different blood-brain-barrier disruption profiles in multiple sclerosis, neuromyelitis optica spectrum disorders, and neuropsychiatric systemic lupus erythematosus.
    Jasiak-Zatońska M, Pietrzak A, Wyciszkiewicz A, Więsik-Szewczyk E, Pawlak-Buś K, Leszczyński P, Kozubski W, Michalak S, Kalinowska-Łyszczarz A.
    Neurol Neurochir Pol; 2022 May 15; 56(3):246-255. PubMed ID: 35118639
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum ROCK2, miR-300 and miR-450b-5p levels in two different clinical phenotypes of multiple sclerosis: Relation to patient disability and disease progression.
    Ibrahim SH, El-Mehdawy KM, Seleem M, El-Sawalhi MM, Shaheen AA.
    J Neuroimmunol; 2020 Oct 15; 347():577356. PubMed ID: 32781341
    [Abstract] [Full Text] [Related]

  • 15. Different Exosomal microRNA Profile in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders.
    Chen C, Wu Y, Li M, Cui C, Zhao Y, Sun X, Wang Y, Liu C, Wu H, Zhong X, Kermode AG, Peng L, Qiu W.
    Front Immunol; 2020 Oct 15; 11():1064. PubMed ID: 32547558
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis.
    Selmaj I, Cichalewska M, Namiecinska M, Galazka G, Horzelski W, Selmaj KW, Mycko MP.
    Ann Neurol; 2017 May 15; 81(5):703-717. PubMed ID: 28411393
    [Abstract] [Full Text] [Related]

  • 19. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
    Vistbakka J, Elovaara I, Lehtimäki T, Hagman S.
    Mult Scler; 2017 Mar 15; 23(3):403-412. PubMed ID: 27246141
    [Abstract] [Full Text] [Related]

  • 20. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
    Komori M, Matsuyama Y, Nirasawa T, Thiele H, Becker M, Alexandrov T, Saida T, Tanaka M, Matsuo H, Tomimoto H, Takahashi R, Tashiro K, Ikegawa M, Kondo T.
    Ann Neurol; 2012 May 15; 71(5):614-23. PubMed ID: 22522477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.